D
Adamis Pharmaceuticals Corporation ADMP
$0.2113 -$0.0087-3.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Weak
Risk Index Weak
Risk Grade D-
Reward Grade D
Rating Factors ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index --
Solvency Index Good
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.46
Price History ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 7.86%
30-Day Total Return 32.15%
60-Day Total Return 48.59%
90-Day Total Return -6.59%
Year to Date Total Return 27.98%
1-Year Total Return -67.24%
2-Year Total Return -85.43%
3-Year Total Return -69.51%
5-Year Total Return -93.96%
52-Week High % Change -70.05%
52-Week Low % Change 83.33%
Price ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.73
52-Week Low Price $0.12
52-Week Low Price (Date) Oct 11, 2022
52-Week High Price (Date) Mar 01, 2022
Valuation ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $33.00M
Enterprise Value 31.57M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.22
Earnings Per Share Growth -52.12%
Price/Earnings To Growth --
Price/Sales (TTM) 21.57
Price/Book (Q) 11.58
Enterprise Value/Revenue (TTM) 20.49
Price $0.21
Enterprise Value/EBITDA (TTM) -1.10
Enterprise Value/EBIT -1.05
Market Cap Category Nano Cap
Dividends and Shares ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 149.983M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 858 997 2400
Address 11682 El Camino Real San Diego, CA 92130
Website www.adamispharmaceuticals.com
Country United States
Year Founded 2006
Profitability ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -1,957.92%
Profit Margin -2,072.23%
Management Effectiveness ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -65.90%
Return on Equity --
Income Statement ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) $1.54M
Total Revenue (TTM) $1.54M
Revenue Per Share $0.01
Gross Profit (TTM) -$3.92M
EBITDA (TTM) -$28.69M
EBIT (TTM) -$30.16M
Net Income (TTM) -$31.92M
Net Income Avl. to Common (TTM) -$31.92M
Total Revenue Growth (Q YOY) 98.12%
Earnings Growth (Q YOY) 17.36%
EPS Diluted (TTM) -$0.22
EPS Diluted Growth (Q YOY) 64.70%
Balance Sheet ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $2.42M
Cash Per Share (Q) $0.02
Total Current Assets (Q) $10.09M
Total Preferred Equity (Q) $0.16
Total Equity (Q) $3.00M
Current Ratio (Q) 1.137
Book Value Per Share (Q) $0.02
Total Assets (Q) $12.14M
Total Current Liabilities (Q) $8.87M
Total Debt (Q) $840.10K
Total Liabilities (Q) $9.13M
Total Common Equity (Q) $2.85M
Cash Flow ADMP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) $4.49M
Cash from Financing (TTM) $242.20K
Net Change in Cash (TTM) -$26.31M
Levered Free Cash Flow (TTM) -$13.28M
Cash from Operations (TTM) -$31.05M
Weiss Ratings